Compound information
- Natural Products
- ZC115372
- Molecular Formula
- C14H21N3O3
- Molecular Weight
- 279.158291532 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1R)-5-amino-1-carbamoyl-pentyl]carbamate
- InChI
- InChI=1S/C14H21N3O3/c15-9-5-4-8-12(13(16)18)17-14(19)20-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10,15H2,(H2,16,18)(H,17,19)/t12-/m1/s1
- InChI Key
- YVKFETNYOZKEGT-GFCCVEGCSA-N
- SMILES
- NCCCC[C@@H](NC(=O)OCc1ccccc1)C(N)=O
- Source
- ZINC000098088496
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 1 |
Heteroatom Count | 6 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 107.44 Å2 | LogP | 0.811 |
LogS | -1.314 | LogD | 1.018 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.033 | Pgp substrate | 0.973 |
HIA | 0.961 | F20 % | 0.994 |
F30 % | 0.373 | Caco-2 | -5.623 |
MDCK | -5.789 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.899 | PPB | 45.681 |
VD | 1.211 | Fu | 0.047 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.029 | CYP1A2 substrate | 0.666 |
CYP2A6 substrate | 0.475 | CYP2B6 substrate | 0.546 |
CYP2C19 inhibitor | 0.143 | CYP2C19 substrate | 0.721 |
CYP2C8 substrate | 0.627 | CYP2C9 inhibitor | 0.043 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.01 |
CYP2D6 substrate | 0.516 | CYP2E1 substrate | 0.573 |
CYP3A4 inhibitor | 0.169 | CYP3A4 substrate | 0.964 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.576 | CL | 4.611 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.032 | Hepatotoxicity | 0.037 |
Mutagenicity | 0.22 | Rat Oral Acute Toxicity | 0.078 |
FDAMDD | 0.038 | Skin Sensitization | 0.002 |
Carcinogenicity | 0.012 | Eye Corrosion | 0.004 |
Eye Irritation | 0.003 | Respiratory Toxicity | 0.015 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.684 | IGC50 | 2.174 |
LC50FM | 3.237 | LC50DM | 4.763 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.153 | NR-AR-LBD | 0.226 |
NR-AhR | 0.003 | NR-Aromatase | 0.03 |
NR-ER | 0.262 | NR-ER-LBD | 0.338 |
NR-PPAR-gamma | 0.237 | SR-ARE | 0.055 |
SR-ATAD5 | 0.315 | SR-HSE | 0.106 |
SR-MMP | 0.008 | SR-p53 | 0.019 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.